Dr. Ahmed Zeeneldine
panellist
Prof Ahmed Zeeneldin
Consultant of Medical Oncology @ King Abdulla Medical City, Makkah, KSA
Professor of Medical Oncology, Cairo univ - NCI, Egypt
Main interests: Breast, Lymphomas, sarcomas and melanomas
Several peer-reviewed international publications,
conference presentations, posters and abstracts
15:00-15:45
Friday 3-5-2024 Day 1
Genomic tools in breast cancer
- chemotherapy in high risk lobular/mucinous BC?
- Neoadjuvant therapy in premenopausal patients with lobular BC?
Adjuvant therapy with node negative and node positive lobular BC?
Adjuvant therapy in luminal BC with RS 16-25?
Can genomic tools guide adjuvant cdk4-6 inhibitors in N0/N1 tumours?? - Oncotype DX and selection of neoadjuvant hormonal vs chemotherapy therapy
- Role of interval Ki67 assessment with neoadjuvant hormonal therapy
Moderator: 
Ahmed Alshehri
Panel:
